Hypoxia primes human normal prostate epithelial cells and cancer cell lines for the NLRP3 and AIM2 inflammasome activation
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
// Ravichandran Panchanathan 1, 2 , Hongzhu Liu 1, 2 , Divaker Choubey 1, 2 1 Cincinnati VA Medical Center, Cincinnati, OH 45220, USA 2 Department of Environmental Health, University of Cincinnati, Cincinnati, OH 45267, USA Correspondence to: Divaker Choubey, email: Divaker.choubey@uc.edu Keywords: hypoxia, prostate, inflammasome, inflammation, cancer Received: December 15, 2015 Accepted: March 28, 2016 Published: April 5, 2016 ABSTRACT The molecular mechanisms by which hypoxia contributes to prostatic chronic inflammation (PCI) remain largely unknown. Because hypoxia stimulates the transcriptional activity of NF-κB, which “primes” cells for inflammasome activation by inducing the expression of NLRP3 or AIM2 receptor and pro-IL-1β, we investigated whether hypoxia could activate the NLRP3 and AIM2 inflammasome in human normal prostate epithelial cells (PrECs) and cancer cell lines. Here we report that hypoxia (1% O 2 ) treatment of PrECs, prostate cell lines, and a macrophage cell line (THP-1) increased the levels of NLRP3, AIM2, and pro-IL-1β. Further, hypoxia in cells potentiated activation of the NLRP3 and AIM2 inflammasome activity. Notably, hypoxia “primed” cells for NLRP3 and AIM2 inflammasome activation through stimulation of the NF-κB activity. Our observations support the idea that hypoxia in human prostatic tumors contributes to PCI, in part, by priming cells for the activation of NLRP3 and AIM2 inflammasome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230 · cited 2×
“com/oncotarget mediated activation of the NF-κB transcriptional activity in myeloid cells “primes” cells (or provides the “first signal”) through the up-regulation of NLRP3 and pro-IL1β protein expression [25, 27], the constitutive activation of the NF-κB activity in prostate cancer cells (such as PC-3 cell line) is p…”
BackgroundOxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068 · cited 3×
“In the presence of oxygen, members of the conserved Egl-Nine (EGLN) gene family (such as EGLN1, EGLN2 and EGLN3) that encode for prolyl hydroxylases in most cell types hydroxylate the HIFα subunit [1, 2].”
BackgroundEltzschig, H. K., & Carmeliet, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0910283 · Cited by 2,061
HIF transcription factors, inflammation, and immunity
Palazon, A., Goldrath, A. W., Nizet, V., & Johnson, R. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.008 · Cited by 1,195 · cited 2×
“g, at 1% O2), HIF-1α is stabilized and it stimulates the transcription of a set of target genes [12, 13] and activates the transcriptional activity of NF-κB [14–17], a master regulator of genes that encode for proinflammatory cytokines such as IL-1β and IL-18 [14, 17].”
BackgroundInterdependence of hypoxic and innate immune responses
Nizet, V., & Johnson, R. S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2607 · Cited by 708
Proline hydroxylation and gene expression
Kaelin, W. G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133142 · Cited by 468
Molecular Mechanism of NLRP3 Inflammasome Activation
Jin, C., & Flavell, R. A. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9440-3 · Cited by 440 · cited 2×
“Although it remains unclear how NLRP3 inflammasome responds to these very diverse stimuli, it has been proposed that the NLRP3 inflammasome is activated by ligand-induced intermediates such as reactive oxygen species (ROS), K+ efflux, and the lysosome destabilization [28].”
BackgroundFang, H.-Y., Hughes, R., Murdoch, C., Coffelt, S. B., Biswas, S. K., Harris, A. L., Johnson, R. S., Imityaz, H. Z., Simon, M. C., Fredlund, E., et al. (2009) · Blood · doi:10.1182/blood-2008-12-195941 · Cited by 319 · cited 7×
“g, at 1% O2), HIF-1α is stabilized and it stimulates the transcription of a set of target genes [12, 13] and activates the transcriptional activity of NF-κB [14–17], a master regulator of genes that encode for proinflammatory cytokines such as IL-1β and IL-18 [14, 17].”
BackgroundInfluentialZhou, J., Schmid, T., & Brüne, B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-09-0598 · Cited by 177
Cited by
Role of the NLRP3 inflammasome in cancer
Moossavi, M., Parsamanesh, N., Bahrami, A., Atkin, S. L., & Sahebkar, A. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0900-3 · Cited by 417
Inflammasome Priming in Sterile Inflammatory Disease
Patel, M. N., Carroll, R. G., Galván-Peña, S., Mills, E. L., Olden, R., Triantafilou, M., Wolf, A. I., Bryant, C. E., Triantafilou, K., & Masters, S. L. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.12.007 · Cited by 241
“Furthermore, hypoxic exposure was found to increase the levels of NLRP3, AIM2, and proIL-1 in human prostate epithelial cells, in prostate cancer cell lines, and in THP-1 cells, and was targeted using an NFκB inhibitor ([23]).”
NLRP3 inflammasome activation in inflammaging
Latz, E., & Duewell, P. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.001 · Cited by 174
Bouhamida, E., Morciano, G., Perrone, M., Kahsay, A. E., Della Sala, M., Wieckowski, M. R., Fiorica, F., Pinton, P., Giorgi, C., & Patergnani, S. (2022) · Biology · doi:10.3390/biology11020300 · Cited by 87
Metadata
- Authors
- Panchanathan, R., Liu, H., & Choubey, D.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-04-05
- Volume
- 7
- Issue
- 19
- Pages
- 28183-28194
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2318784432
- Cited by
- 46
- References
- 9
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.